Intercure Ltd.
INCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001857030
No open-market purchases or sales by Intercure Ltd. insiders were filed in the last 90 days; 16 institutions reported holding it in 13F filings for Q2 2026, worth $764.1K in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Intercure Ltd. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Of which not filed for Q2 2023 | Q2 2023 | Change |
|---|---|---|---|---|
| Holders | 18 | 1 | 19 | +2 |
| Shares | 4.06M | 811.3K | 3.10M | −145.3K (−4.5%) |
| Value | $8.29M | $1.66M | $5.30M | −$1.34M (−20.2%) |
1 institution that held it in Q1 2023 haven't filed for Q2 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (5)
Institutions that held Intercure Ltd. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Cambria Investment Management, L.P. | 57,995 | $98.6K | 0.01% |
| Connective Capital Management, LLC | 25,089 | $42.7K | 0.05% |
| Susquehanna International Group, LLP | 12,727 | $21.6K | 0.00% |
| Toronto Dominion Bank | 313 | $0 | 0.00% |
| Royal Bank of Canada | 190 | $0 | 0.00% |
Sold out (3)
Institutions that held Intercure Ltd. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Virtu Financial LLC | 16,796 | $34.0K |
| UBS Group AG | 1,698 | $3.46K |
| JPMorgan Chase & Co | 98 | $0 |
Not filed for Q2 2023 yet (1)
Institutions that held Intercure Ltd. at the end of Q1 2023 and haven't filed a 13F for Q2 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| ETF Managers Group, LLC | 811,283 | $1.66M |